✦ LIBER ✦

A functional analysis and treatment of the irrational and rational statements of an elderly woman with Alzheimer's disease

✍ Scribed by Sandra Beaton; Colin M. Peeler; Thomas Harvey

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 102 KB
Volume: 21
Category: Article
ISSN: 1072-0847
DOI: 10.1002/bin.206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of donepezil and galantamin

A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis

✍ Robin D. J. Harry; Konstantine K. Zakzanis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

This review was conducted in order to determine the efficacy of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease, and also to determine whether galantamine was a superior pharmacological intervention. Meta-analytic methods were used to analyse the data from eig

The effect of selegiline in the treatmen

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials

✍ G. K. Wilcock; J. Birks; A. Whitehead; Sir John Grimley Evans 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## Objective To evaluate the effect of selegiline in the treatment of patients with Alzheimer's disease, in terms of cognitive performance, functional ability, emotional state (including behaviour and mood) and global response. ## Data Sources The Cochrane database of trials, Embase,

Visualizing disease associations: graphi

Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease

✍ Haydeh Payami; Denise M. Kay; Cyrus P. Zabetian; Gerard D. Schellenberg; Stewart 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

## Abstract Age‐related variation in marker frequency can be a confounder in association studies, leading to both false‐positive and false‐negative findings and subsequently to inconsistent reproducibility. We have developed a simple method, based on a novel extension of moving average plots (MAP),

The place of memantine in the treatment

The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

✍ Gill Livingston; Cornelius Katona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## Introduction Memantine is currently the only treatment approved for moderately severe to severe Alzheimer's disease (AD). There is still some discussion as to its place in clinical practice and many UK clinicians are discouraged for economic reasons from prescribing it. We adopt a ‘

Olanzapine in the treatment of anxiety s

Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis

✍ Jacobo Mintzer; Warachal Faison; Jamie S. Street; Virginia K. Sutton; Alan Breie 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The efficacy and safety of risperidone i

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials

✍ Ira Katz; Peter-Paul de Deyn; Jacobo Mintzer; Andrew Greenspan; Young Zhu; Henry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Abstract ## Background Dementia typically includes behavioral and psychological symptoms of dementia (BPSD) as well as cognitive decline. Psychosis of Alzheimer's disease (AD) is a specific component of AD, characterized by delusions, misidentifications, and hallucinations. ## Methods This st